Molina Healthcare (MOH) | Financial Analysis & Statements
Molina Healthcare Inc. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
11.4B
Gross Profit
701.0M
6.16%
Operating Income
-162.0M
-1.42%
Net Income
-160.0M
-1.41%
EPS (Diluted)
$-3.15
Balance Sheet Metrics
Total Assets
15.6B
Total Liabilities
11.5B
Shareholders Equity
4.1B
Debt to Equity
2.83
Cash Flow Metrics
Operating Cash Flow
-276.0M
Free Cash Flow
-297.0M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Molina Healthcare Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 45.4B | 40.6B | 34.1B | 32.0B | 27.8B |
| Cost of Goods Sold | 41.4B | 35.9B | 29.7B | 28.0B | 24.5B |
| Gross Profit | 4.1B | 4.7B | 4.3B | 3.9B | 3.3B |
| Gross Margin % | 9.0% | 11.7% | 12.7% | 12.3% | 11.8% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 3.0B | 2.7B | 2.5B | 2.3B | 2.1B |
| Other Operating Expenses | 90.0M | 100.0M | 128.0M | 58.0M | 61.0M |
| Total Operating Expenses | 3.1B | 2.8B | 2.6B | 2.4B | 2.1B |
| Operating Income | 781.0M | 1.7B | 1.6B | 1.4B | 1.0B |
| Operating Margin % | 1.7% | 4.2% | 4.6% | 4.3% | 3.7% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 192.0M | 118.0M | 109.0M | 110.0M | 120.0M |
| Other Non-Operating Income | - | - | - | -208.0M | -25.0M |
| Pre-tax Income | 589.0M | 1.6B | 1.5B | 1.1B | 875.0M |
| Income Tax | 117.0M | 410.0M | 373.0M | 271.0M | 216.0M |
| Effective Tax Rate % | 19.9% | 25.8% | 25.5% | 25.5% | 24.7% |
| Net Income | 472.0M | 1.2B | 1.1B | 792.0M | 659.0M |
| Net Margin % | 1.0% | 2.9% | 3.2% | 2.5% | 2.4% |
| Key Metrics | |||||
| EBITDA | 976.0M | 1.9B | 1.7B | 1.6B | 1.1B |
| EPS (Basic) | $8.93 | $21.05 | $18.71 | $13.66 | $11.36 |
| EPS (Diluted) | $8.92 | $20.42 | $18.71 | $13.55 | $11.25 |
| Basic Shares Outstanding | 52800000 | 56000000 | 58300000 | 58000000 | 58000000 |
| Diluted Shares Outstanding | 52800000 | 56000000 | 58300000 | 58000000 | 58000000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Molina Healthcare Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 4.2B | 4.7B | 4.8B | 4.0B | 4.4B |
| Short-term Investments | 4.0B | 4.3B | 4.3B | 3.5B | 3.2B |
| Accounts Receivable | 3.5B | 3.3B | 2.7B | 2.0B | 1.8B |
| Inventory | - | - | - | - | - |
| Other Current Assets | 655.0M | 487.0M | 331.0M | 277.0M | 247.0M |
| Total Current Assets | 12.4B | 12.8B | 12.5B | 10.1B | 10.1B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 261.0M | 270.0M | 266.0M | 293.0M | 206.0M |
| Goodwill | 4.2B | 3.6B | 2.7B | 2.5B | 2.2B |
| Intangible Assets | 237.0M | 267.0M | 208.0M | 275.0M | 270.0M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 624.0M | 631.0M | 631.0M | 581.0M | 497.0M |
| Total Non-Current Assets | 3.1B | 2.9B | 2.4B | 2.2B | 2.1B |
| Total Assets | 15.6B | 15.6B | 14.9B | 12.3B | 12.2B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 1.1B | 1.3B | 1.3B | 889.0M | 842.0M |
| Short-term Debt | - | - | - | - | - |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 7.4B | 7.9B | 8.2B | 6.9B | 7.0B |
| Non-Current Liabilities | |||||
| Long-term Debt | 4.0B | 3.1B | 2.4B | 2.4B | 2.4B |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 173.0M | 120.0M | 124.0M | 104.0M | 140.0M |
| Total Non-Current Liabilities | 4.1B | 3.2B | 2.5B | 2.5B | 2.5B |
| Total Liabilities | 11.5B | 11.1B | 10.7B | 9.4B | 9.6B |
| Equity | |||||
| Common Stock | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 3.6B | 4.1B | 3.9B | 2.8B | 2.4B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 4.1B | 4.5B | 4.2B | 3.0B | 2.6B |
| Key Metrics | |||||
| Total Debt | 4.0B | 3.1B | 2.4B | 2.4B | 2.4B |
| Working Capital | 5.1B | 4.9B | 4.4B | 3.2B | 3.0B |
Balance Sheet Composition
Molina Healthcare Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 472.0M | 1.2B | 1.1B | 792.0M | 659.0M |
| Depreciation & Amortization | 195.0M | 186.0M | 171.0M | 176.0M | 131.0M |
| Stock-Based Compensation | 47.0M | 116.0M | 115.0M | 103.0M | 72.0M |
| Working Capital Changes | -618.0M | -348.0M | -393.0M | -49.0M | -275.0M |
| Operating Cash Flow | 136.0M | 1.2B | 955.0M | 964.0M | 596.0M |
| Investing Activities | |||||
| Capital Expenditures | -101.0M | -100.0M | -84.0M | -91.0M | -77.0M |
| Acquisitions | -245.0M | -344.0M | -3.0M | -134.0M | -129.0M |
| Investment Purchases | -751.0M | -1.1B | -1.4B | -1.9B | -2.7B |
| Investment Sales | 1.4B | 1.1B | 772.0M | 1.4B | 1.3B |
| Investing Cash Flow | 312.0M | -464.0M | -744.0M | -790.0M | -1.7B |
| Financing Activities | |||||
| Share Repurchases | -1.0B | -1.0B | 0 | -400.0M | -128.0M |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 1.9B | 1.0B | 0 | 0 | 740.0M |
| Debt Repayment | -1.1B | -300.0M | 0 | 0 | -723.0M |
| Financing Cash Flow | -170.0M | -347.0M | -58.0M | -441.0M | -183.0M |
| Free Cash Flow | -636.0M | 544.0M | 1.6B | 682.0M | 2.0B |
| Net Change in Cash | 278.0M | 383.0M | 153.0M | -267.0M | -1.2B |
Cash Flow Trend
Molina Healthcare Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
16.83
Forward P/E
18.42
Price to Book
1.89
Price to Sales
0.18
PEG Ratio
-0.10
Profitability Ratios
Profit Margin
1.08%
Operating Margin
-1.50%
Return on Equity
11.02%
Return on Assets
3.14%
Financial Health
Current Ratio
1.69
Debt to Equity
99.44
Beta
0.55
Per Share Data
EPS (TTM)
$8.97
Book Value per Share
$79.78
Revenue per Share
$825.06
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| MOH | 9.1B | 16.83 | 1.89 | 11.02% | 1.08% | 99.44 |
| UnitedHealth | 322.3B | 26.81 | 3.42 | 12.18% | 2.68% | 73.98 |
| CVS Health | 101.1B | 55.65 | 1.31 | 2.29% | 0.44% | 106.06 |
| Oscar Health | 4.9B | 34.55 | 5.00 | -44.35% | -3.79% | 50.86 |
| Alignment Healthcare | 4.3B | - | 24.07 | -0.70% | -0.02% | 184.97 |
| Elevance Health | 76.4B | 13.19 | 1.67 | 13.25% | 2.84% | 74.39 |
Financial data is updated regularly. All figures are in the company's reporting currency.






